Please login (Members) to view content or
(Nonmembers) this article.
0
No votes yet
Online Exclusive Article

Anthracycline Chemotherapy–Induced Cardiotoxicity in Breast Cancer Survivors: A Systematic Review

Katherine Jinghua Lin
Cecile A. Lengacher
ONF 2019, 46(5), E145-E158 DOI: 10.1188/19.ONF.E145-E158

Problem Identification: This review identifies specific cardiotoxicity related to anthracycline chemotherapy, specific risk factors related to increased anthracycline chemotherapy–induced cardiotoxicity, and underlying mechanisms of action of anthracycline chemotherapy–induced cardiotoxicity.

Literature Search: PubMed®, CINAHL®, Embase®, and Web of Science were searched in May 2018 using keywords related to heart diseases, anthracycline chemotherapy, and breast cancer.

Data Evaluation: Data were extracted, and study quality was assessed according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines.

Synthesis: 1,117 articles were identified through the literature search. After a review of the abstracts and articles, 15 clinical studies were identified for the final analysis by using exclusion and inclusion criteria.

Implications for Practice: Nurses should recognize the critical elements for prevention and early detection of anthracycline chemotherapy–induced cardiotoxicity.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or